USMLE Step 2 CK practice question: Hepatitis B immunoprophylaxis for a preterm infant of an HBsAg-positive mother

USMLE Step 2 CKPediatricsPediatrics

A male newborn is delivered at 33 weeks' gestation by cesarean delivery because of preterm labor with breech presentation. Birth weight is 1,750 g (3 lb 14 oz). Apgar scores are 7 and 9 at 1 and 5 minutes, respectively. The mother is a 29-year-old woman, gravida 2, para 1, who tested positive for hepatitis B surface antigen (HBsAg) at her first-trimester prenatal visit; hepatitis B e antigen was negative, and HBV DNA was 1,800 IU/mL, so she did not receive antiviral therapy during pregnancy. She is HIV-negative. The infant is now 2 hours old, is breathing comfortably on room air in the neonatal intensive care unit, and is hemodynamically stable. The mother plans to breastfeed.

Which of the following is the most appropriate management to prevent perinatal hepatitis B transmission in this infant?

  1. Hepatitis B vaccine within 12 hours, with hepatitis B immune globulin deferred until the infant's HBsAg status is known
  2. Hepatitis B immune globulin now, with the first vaccine dose given when the infant reaches 2,000 g
  3. Hepatitis B vaccine and hepatitis B immune globulin within 12 hours of birth, followed by 3 additional vaccine doses
  4. Hepatitis B vaccine and hepatitis B immune globulin within 12 hours of birth, followed by 2 additional vaccine doses
  5. Hepatitis B vaccine and hepatitis B immune globulin within 12 hours of birth, and advise the mother not to breastfeed
Show answer and explanation

Correct answer: C. Hepatitis B vaccine and hepatitis B immune globulin within 12 hours of birth, followed by 3 additional vaccine doses

Infants born to mothers who are positive for hepatitis B surface antigen (HBsAg) are at high risk of perinatal HBV transmission. Without immunoprophylaxis, 70–90% of infants of HBeAg-positive mothers become infected (the risk is lower but still substantial with HBeAg-negative mothers), and about 90% of infants infected perinatally develop chronic infection, with long-term risks of cirrhosis and hepatocellular carcinoma. Combined passive-active immunoprophylaxis — single-antigen hepatitis B vaccine plus hepatitis B immune globulin (HBIG, 0.5 mL IM, given at a different anatomic site) within 12 hours of birth — prevents most of these infections. This applies to every infant of an HBsAg-positive mother regardless of birth weight, gestational age, or clinical status. The December 2025 ACIP changes to the hepatitis B birth-dose recommendation concern infants of HBsAg-negative mothers; recommendations for infants of HBsAg-positive (or unknown-status) mothers are unchanged.

Preterm infants weighing <2,000 g have a reduced antibody response to the birth dose, so that dose is not counted toward the vaccine series. These infants need 3 additional doses beginning at 1 month of chronological age (typically at 1, 2–3, and 6 months; 4 doses in total). All infants of HBsAg-positive mothers should undergo post-vaccination serologic testing (HBsAg and anti-HBs) at 9–12 months of age, or 1–2 months after the final dose if the series is delayed. Breastfeeding is not contraindicated.

High-yield summary: HBsAg-positive mother → hepatitis B vaccine + HBIG within 12 hours of birth for every infant; if birth weight is <2,000 g, the birth dose does not count (give 3 more doses); test HBsAg and anti-HBs at 9–12 months; encourage breastfeeding.

Why the other options are wrong

  • A. Hepatitis B vaccine within 12 hours, with hepatitis B immune globulin deferred until the infant's HBsAg status is known — HBIG must be given together with the vaccine within 12 hours of birth; waiting for the infant's HBsAg result forfeits the window for passive immunoprophylaxis.
  • B. Hepatitis B immune globulin now, with the first vaccine dose given when the infant reaches 2,000 g — Deferring the first vaccine dose (to 1 month of chronological age or hospital discharge) is an option only for medically stable preterm infants weighing <2,000 g who are born to HBsAg-negative mothers; an exposed infant needs both vaccine and HBIG within 12 hours of birth.
  • D. Hepatitis B vaccine and hepatitis B immune globulin within 12 hours of birth, followed by 2 additional vaccine doses — A birth dose followed by 2 more doses completes the series only in infants weighing ≥2,000 g; in infants <2,000 g, the birth dose is not counted, so 3 additional doses are required.
  • E. Hepatitis B vaccine and hepatitis B immune globulin within 12 hours of birth, and advise the mother not to breastfeed — Breastfeeding does not increase the risk of HBV transmission in infants who receive appropriate immunoprophylaxis and should be encouraged.

Key point

Every infant of an HBsAg-positive mother should receive hepatitis B vaccine and HBIG within 12 hours of birth; in infants weighing <2,000 g, the birth dose is not counted, and 3 additional doses are required.

Memory hook

HBsAg+ mom → vaccine + HBIG within 12 h, any weight. Under 2 kg, birth dose = 'practice shot': doesn't count, give 3 more.

Share: Telegram WhatsApp X LinkedIn

Practice like this every day

15 free bank questions a day, exam-length timed blocks, spaced repetition and 3D anatomy — in English and Russian.

Play free

More free questions in this system

Inferior STEMI with right ventricular infarction and hypotensionUSMLE Step 2 CK · CardiovascularDiabetic ketoacidosis with hypokalemia: potassium before insulinUSMLE Step 2 CK · EndocrineEmpiric therapy for community-acquired bacterial meningitis in an adult older than 50 yearsUSMLE Step 2 CK · NervousDrug-induced hyperkalemia with ECG changes: immediate intravenous calciumUSMLE Step 2 CK · RenalGiant cell arteritis with transient monocular vision loss: IV pulse glucocorticoids before biopsyUSMLE Step 2 CK · MusculoskeletalPainless third-trimester bleeding: ultrasonography before digital examination (placenta previa)USMLE Step 2 CK · Pregnancy

All free questions →